Animab
Animab is developing antibodies that can be administered orally to animals.
Ghent, Belgiumwww.animab.com ↗
Total raised
€10M
€10,000,000
Funding rounds
1
Investors
6
distinct backers
Active since
2022-11
latest 2022-11
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-09 | Series A | €10M | AIF,PMV,Qbic III ,Seventure Partners,V-Bio Ventures,VIB | View deal → |
Related news
- Gentse biotech start-up trekt 10 miljoen euro kapitaal aanbloovi.be · 2022-11